Literature DB >> 34134509

Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes.

Monique F Kilkenny1,2, Hoang T Phan1,3, Richard I Lindley4,5, Joosup Kim1,2, Derrick Lopez6, Lachlan L Dalli1, Rohan Grimley1,7, Vijaya Sundararajan8, Amanda G Thrift1, Nadine E Andrew1,9, Geoffrey A Donnan10, Dominique A Cadilhac1,2.   

Abstract

Background and Purpose: Conditions associated with frailty are common in people experiencing stroke and may explain differences in outcomes. We assessed associations between a published, generic frailty risk score, derived from administrative data, and patient outcomes following stroke/transient ischemic attack; and its accuracy for stroke in predicting mortality compared with other measures of clinical status using coded data.
Methods: Patient-level data from the Australian Stroke Clinical Registry (2009–2013) were linked with hospital admissions data. We used International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes with a 5-year look-back period to calculate the Hospital Frailty Risk Score (termed Frailty Score hereafter) and summarized results into 4 groups: no-risk (0), low-risk (1–5), intermediate-risk (5–15), and high-risk (>15). Multilevel models, accounting for hospital clustering, were used to assess associations between the Frailty Score and outcomes, including mortality (Cox regression) and readmissions up to 90 days, prolonged acute length of stay (>20 days; logistic regression), and health-related quality of life at 90 to 180 days (quantile regression). The performance of the Frailty Score was then compared with the Charlson and Elixhauser Indices using multiple tests (eg, C statistics) for predicting 30-day mortality. Models were adjusted for covariates including sociodemographics and stroke-related factors.
Results: Among 15 468 adult patients, 15% died ≤90 days. The frailty scores were 9% no risk; 23% low, 45% intermediate, and 22% high. A 1-point increase in frailty (continuous variable) was associated with greater length of stay (ORadjusted, 1.05 [95% CI, 1.04 to 1.06), 90-day mortality (HRadjusted, 1.04 [95% CI, 1.03 to 1.05]), readmissions (ORadjusted, 1.02 [95% CI, 1.02 to 1.03]; and worse health-related quality of life (median difference, −0.010 [95% CI −0.012 to −0.010]). Adjusting for the Frailty Score provided a slightly better explanation of 30-day mortality (eg, larger C statistics) compared with other indices. Conclusions: Greater frailty was associated with worse outcomes following stroke/transient ischemic attack. The Frailty Score provides equivalent precision compared with the Charlson and Elixhauser indices for assessing risk-adjusted outcomes following stroke/transient ischemic attack.

Entities:  

Keywords:  hospitalization; ischemic attack, transient; mortality; register; risk factor

Mesh:

Year:  2021        PMID: 34134509     DOI: 10.1161/STROKEAHA.120.033648

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Prevalence and implications of frailty in acute stroke: systematic review & meta-analysis.

Authors:  Jennifer K Burton; Jennifer Stewart; Mairi Blair; Sinead Oxley; Amy Wass; Martin Taylor-Rowan; Terence J Quinn
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 12.782

2.  Higher Hospital Frailty Risk Score is associated with increased complications and healthcare resource utilization after endovascular treatment of ruptured intracranial aneurysms.

Authors:  Andrew B Koo; Aladine A Elsamadicy; Daniela Renedo; Margot Sarkozy; Josiah Sherman; Benjamin C Reeves; John Havlik; Joseph Antonios; Nanthiya Sujijantarat; Ryan Hebert; Ajay Malhotra; Charles Matouk
Journal:  J Neurointerv Surg       Date:  2022-03-15       Impact factor: 8.572

Review 3.  The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature.

Authors:  Muideen T Olaiya; Nita Sodhi-Berry; Lachlan L Dalli; Kiran Bam; Amanda G Thrift; Judith M Katzenellenbogen; Lee Nedkoff; Joosup Kim; Monique F Kilkenny
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-11       Impact factor: 5.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.